5002882025-03-182025-03-185002882025-03-185002882025-03-182025-03-18PartiesOfTheAgreementDomain15002882025-03-18PartiesOfTheAgreementDomain15002882025-03-182025-03-18PartiesOfTheAgreementDomain25002882025-03-18PartiesOfTheAgreementDomain2xbrli:pureMOREPEN LABORATORIES LIMITEDMOREPENLABNewOthersBusiness Transfer AgreementExecution of agreementListed Entity,Related Parties of the listed entityfalse2025-03-1811:45:00true2025-03-18Business Transfer Agreement with Morepen Medtech Limited, a subsidiary of the Company, for the hiving-off of Medical Devices Business on a ‘slump sale’ as a going concern basis.falsePursuant to approval of the members of the Company at the Extra-Ordinary General Meeting held on February 10, 2025, the Company has today i.e., March 18, 2025, executed the BTA with Morepen Medtech Limited, a subsidiary of the Company, for the hiving-off of Medical Devices Business on a ‘slump sale’ as a going concern basis.No2Morepen Laboratories LimitedParty entering into the agreementNot ApplicabletrueThe Company itself is a party to the agreement.Morepen Medtech LimitedParty entering into the agreementThe Company holds 80% paid-up equity share capital in Morepen Medtech LimitedtrueMorepen Medtech Limited has been incorporated as a subsidiary of the company, with an aggregate shareholding of 20% of the entities belonging to the promoters’ group/ relatives of promoter/ members of promoter group.truetrue2025-03-18The Company has executed a Business Transfer Agreement (‘BTA’) with Morepen Medtech Limited for hiving-off of Medical Devices Business, being an undertaking of the Company, on ‘slump sale’ as a going concern basis.The transfer of all rights, title, and interest in the undertaking on a slump sale as a going concern basis, based on the valuation arrived under Rule 11UAE of the Income Tax Rules, 1962. The final consideration will be subject to adjustments based on the closing terms and conditions. Other terms are standard terms/ covenants of the BTA.falseNo